✦ LIBER ✦

Combining day patient treatment with family work in a child psychiatry clinic

✍ Scribed by Maurice Place; Selowa Rajah; Thomas Crake

Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 782 KB
Volume: 239
Category: Article
ISSN: 1433-8491
DOI: 10.1007/bf01734545

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Working with families of severely distur

Working with families of severely disturbed children in a day treatment setting

✍ Cecille H. Burroughs 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 784 KB

A clinical study of combination of radio

A clinical study of combination of radiotherapy and IP regimen in the treatment of patients with local advanced esophageal cancer

✍ Fei Gao; Lin Jia; Huizhang Du; Xiaohong Kuang; Yun Wang; Jianjun Han 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 81 KB

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

The PREMIER study: A multicenter, random

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

✍ Ferdinand C. Breedveld; Michael H. Weisman; Arthur F. Kavanaugh; Stanley B. Cohe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views